NASDAQ$PLRX

Pliant Therapeutics Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

PLRX Q2 2024 — $200K revenue, 0.92 EPS

Quarterly Report on Form 10-Q, or this Report, contains forward-looking statements that involve risks, uncertainties, and assumptions that, if they never materialize or prove incorrect, could cause ou. Pliant Therapeutics Inc reported Q2 2024 results. Diluted EPS came in at $0.92. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.

  • Revenue: $200K.
  • Diluted EPS: $0.92.
  • Operating income: $61K.

Headline financials

Total Revenue

$0.00

Previous: $248K-100.0%
EPS

-$0.92

Previous: -$0.70-31.4%
Capital Expenditures

-$2.74M

Previous: -$766K-258.1%
Free Cash Flow

-$58.6M

Previous: -$42M-39.7%
Net Income

-$55.9M

Previous: -$41.2M-35.6%
Operating Income

-$60.6M

Previous: -$47.3M-28.1%
Cash & Equivalents

$80.4M

Previous: $55M+46.3%
Total Assets

$484M

Previous: $575M-15.9%
R&D Expense

$45M

No prior period
Stock-Based Comp

$10.6M

Previous: $13M-18.4%

Revenue & EPS history

Pliant Therapeutics · Revenue · Quarterly

$0

Q2 2024-100%vs Q2 2023
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-1.8%

Avg return

Earnings day

-2.4%

Avg return

5 days after

-4.2%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+12.1%

Q3 2020

Best reaction

-11.7%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+0.8%-4.2%-4.2%
Q3 2025+3.3%+17.6%-20.9%
Q1 2025-1.5%-2.9%-1.4%
Q4 2024-11.7%+17.4%-5.1%
Q3 2024-4.5%-12.0%-6.4%
Q2 2024-6.5%-9.6%-1.8%
Q1 2024-1.4%-1.2%-13.4%
Q4 2023-7.8%-4.8%-13.4%
Q3 2023-8.0%-12.4%-2.7%
Q2 2023+3.4%-0.9%-9.5%
Q1 2023+4.2%-0.0%+3.0%
Q4 2022-10.9%-9.4%-17.6%
Q3 2022-6.5%-6.7%-14.5%
Q2 2022+11.9%+12.6%+6.2%
Q1 2022-6.8%-1.8%+40.5%
Q4 2021+3.7%-9.9%-26.6%
Q3 2021-4.0%-3.2%-17.9%
Q2 2021-6.5%-12.4%-15.7%
Q1 2021-0.1%-14.7%-3.1%
Q4 2020+4.6%+2.5%-19.9%
Q3 2019+12.1%+9.9%+21.2%
Q3 2020+12.1%+9.9%+21.2%
Q2 2020-8.5%-8.2%-1.2%
Q4 2019-8.5%-8.2%-1.2%
Q2 2019-8.5%-8.2%-1.2%
Q1 2020
Q1 2019
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro